![]() SurModics SurModics is a provider of surface modification, drug delivery and in vitro diagnostic technologies to the healthcare industry. | ![]() SiteOne Therapeutics SiteOne Therapeutics is a company that develops therapeutics for the treatment of hypersensitivity disorders. | ![]() Inflazome Inflazome engages in developing orally available drugs to address clinical unmet needs in inflammatory diseases by targeting the inflammasome. | |
Founding Date | Founding Date 1979 | Founding Date 2014 | Founding Date 2016 |
Type | Type Public | Type Private | Type Subsidiary |
Tags | |||
Locations | Locations Eden Prairie, US HQ Galway, IE Eden Prairie, US | Locations San Francisco, US HQ Bozeman, US | Locations Dublin 2, IE HQ Brisbane City, AU Cambridge, GB |
Employees | Employees 3699% increase | Employees 2216% increase | Employees 156% decrease |
Valuation ($) | Valuation ($) 539.3 m | Valuation ($) 75 m | Valuation ($) N/A |
Funding | |||
Total funding raised | Total funding raised N/A | Total funding raised $ 17.8m | Total funding raised $ 17m |

SiteOne Therapeutics is a company that develops therapeutics for the treatment of hypersensitivity disorders.
View company
Inflazome engages in developing orally available drugs to address clinical unmet needs in inflammatory diseases by targeting the inflammasome.
View company